by Dr. Joseph Mercola, Mercola: STORY AT-A-GLANCE The COVID-19 pandemic has been a real boon to Pfizer. Not only has it doubled Pfizer’s annual revenue, it has also given the drugmaker unique weight in determining U.S. health policy — something that concerns even staunch vaccine-pushers like Dr. Paul Offit Pfizer’s revenue in 2021 was $81.3 […]
Source